1. WE ARE EAGER TO DISCUSS OPENLY WITH YOU
If you are as excited as we are and highly value this investment opportunity in terms of not only high potential return but also high impact you will help to make on public health, please do contact us by:
Email: Please click here to send us an email
You could also directly contact Dr. Jiasheng (Jason) Song, the Founder and the Chief Scientific Officer (CSO) of the AhR Pharmaceuticals, Inc. by:
Email: Please click here to send an email to Dr. Song
Phone: (608) 692-4791
Fax: (608) 848-2558
Post Mail:
AhR Pharmaceuticals, Inc. 7880 Wood Reed Dr. Madison, WI 53719
2. INTELLECTUAL PROPERTY POSTION OF THE COMPANY
2.1. Intellectual Property Owned by the AhR Pharmaceuticals
2.2. Intellectual Property Owned by the WARF
The intellectual property owned by the Wisconsin Alumni Research Foundation (WARF) is licensed to the AhR Pharmaceuticals, Inc.
2.2.1. Inventors of the WARF intellectual property
The foundational intellectual property supporting the technology platform of the company was developed by Dr. Jiasheng (Jason) Song (the founder of the company), Dr. Hector F. Deluca, and their colleagues. Since Dr. Song and his colleagues were in the Department of Biochemistry at the University of Wisconsin-Madison when the invention was made, they are inventors but not owners of the intellectual property.
2.2.2. Patents in the WARF intellectual property package
-
An issued US patent (US 6,916,834 B2): Preparation and uses of an Ah receptor ligand, 2-(1'H-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester. The patent covers therapeutic uses of the ITE hormone.
-
An issued US patent (US 7,419,992 B2): Use of aryl hydrocarbon receptor ligand as a therapeutic intervention in angiogenesis-implicated disorders. The patent covers the use of ITE in therapeutic intervention of angiogenesis implicated disorders.
3. INVESTOR TAX CREDIT PROGRAM OF WISCONSIN
To assist early-stage businesses conducting pre-commercialization activity related to proprietary technologies in their efforts to attract investors, the State of Wisconsin makes state tax credits available to individuals and groups investing in these businesses. In order for investors being able to take the credits, the business they invested in needs to be designated/certified as Qualified New Business Ventures (QNBV) by Wisconsin Department of Commerce.
The AhR Pharmaceuticals, Inc. was recently certified by the Wisconsin Department of Commerce as a QNBV (Qualified New Business Venture) for that purpose. To obtain a copy of this certificate, please click here. To view a list of QNBV of Wisconsin, please click this. For more information about this wonderful program and, importantly, what the Department of Commerce would NOT endorse in relation to this certification, please visit the Wisconsin Department of Commerce website.
